{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T08:27:55Z","timestamp":1791966475770,"version":"4.3.4"},"reference-count":95,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>Due to the sudden emergence and burnout nature of Marburg virus (MARV) outbreaks, little is known about MARV\u2019s pathogenicity and immunogenicity. These gaps in knowledge are limiting our understanding of the disease and the implementation of cost-effective prevention and control measures including case management through safe and effective therapeutic modalities. Therefore, this review aims to synthesize and summarize evidence about pathogenicity, immunogenicity, and virulence in humans towards MARV. Upon infection, MARV rapidly disseminates throughout various tissues, provoking severe cellular injury, particularly in lymphatic organs, the liver, kidneys, and the gastrointestinal tract. The virus takes advantage of host cells by avoiding immune responses, mainly by disrupting the function of dendritic cells and blocking the signaling pathways for interferon. As a result, patients experience profound immune dysregulation characterized by early lymphocyte depletion and a shift towards pro-inflammatory cytokine release, resulting in a cytokine storm that can lead to hemorrhagic septic shock. Additionally, adaptive immune responses, including antibody production, are impaired, further complicating recovery and increasing susceptibility to severe disease outcomes. Understanding these intricate host\u2013pathogen interactions is critical for developing effective therapeutic strategies and vaccines against MARV. Continuing research is essential to explain the mechanisms of immune evasion and to identify potential intervention points for improving patient outcomes.<\/jats:p>","DOI":"10.3390\/pathogens14040323","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T04:11:40Z","timestamp":1743135100000},"page":"323","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Immunogenicity, Pathogenesis, and Host\u2019s Immuno-Responses to Marburg Virus Infection"],"prefix":"10.3390","volume":"14","author":[{"given":"Emmanuel Edwar","family":"Siddig","sequence":"first","affiliation":[{"name":"Rwanda Biomedical Center (RBC), Kigali KG 644 St, Rwanda"},{"name":"The Africa Centres for Disease Control and Prevention (Africa CDC), Ring Road, 16\/17, Haile Garment Lafto Square, Addis Ababa P.O. Box 3243, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicaise","family":"Ndembi","sequence":"additional","affiliation":[{"name":"The International Vaccine Institute (IVI), Africa Regional Office (IARO), Kigali KN 78 St, Rwanda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9516-9508","authenticated-orcid":false,"given":"Ayman","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Rwanda Biomedical Center (RBC), Kigali KG 644 St, Rwanda"},{"name":"Pan-Africa One Health Institute (PAOHI), Kigali KG 203 St, Rwanda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4180-442X","authenticated-orcid":false,"given":"Claude Mambo","family":"Muvunyi","sequence":"additional","affiliation":[{"name":"Rwanda Biomedical Center (RBC), Kigali KG 644 St, Rwanda"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"001955","DOI":"10.1099\/jgv.0.001955","article-title":"ICTV Virus Taxonomy Profile: Filoviridae 2024","volume":"105","author":"Biedenkopf","year":"2024","journal-title":"J. Gen. Virol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Muvunyi, C.M., Mohamed, N.S., Siddig, E.E., and Ahmed, A. (2024). Genomic Evolution and Phylodynamics of the Species Orthomarburgvirus Marburgense (Marburg and Ravn Viruses) to Understand Viral Adaptation and Marburg Virus Disease\u2019s Transmission Dynamics. Pathogens, 13.","DOI":"10.3390\/pathogens13121107"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Muvunyi, C.M., Ngabonziza, J.C.S., Bigirimana, N., Ndembi, N., Siddig, E.E., Kaseya, J., and Ahmed, A. (2024). Evidence-Based Guidance for One Health Preparedness, Prevention, and Response Strategies to Marburg Virus Disease Outbreaks. Diseases, 12.","DOI":"10.3390\/diseases12120309"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Muvunyi, C.M., Bigirimana, N., Tuyishime, A., Mukagatare, I., Ngabonziza, J.C., and Ahmed, A. (2024, October 03). Initiatives and Strategies to Strengthen the National, Regional, and International Global Health Security: A Case Study of Rwanda Biomedical Centre. Available online: https:\/\/ssrn.com\/abstract=4957490.","DOI":"10.2139\/ssrn.4957490"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Gashegu, M., Ahmed, A., Clarisse, M., Remera, E., Tuyishime, A., Rwagasore, E., Muhizi, D., Kanesa, N., Ndayisenga, F., and Thadee, T. (2024, November 13). One Health Prioritization for Zoonotic Diseases of Public Health Importance in Rwanda. Available online: https:\/\/papers.ssrn.com\/sol3\/papers.cfm?abstract_id=4957490.","DOI":"10.2139\/ssrn.5016427"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1093\/trstmh\/trv024","article-title":"Mapping the Zoonotic Niche of Marburg Virus Disease in Africa","volume":"109","author":"Pigott","year":"2015","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_7","unstructured":"WHO (2019, May 19). List of Blueprint Priority Diseases. Available online: https:\/\/www.who.int\/activities\/prioritizing-diseases-for-research-and-development-in-emergency-contexts\/."},{"key":"ref_8","unstructured":"The Global Alliance for Vaccines and Immunizations (GAVI) (2024, October 10). The Next Pandemic: Marburg?. Available online: https:\/\/www.gavi.org\/vaccineswork\/next-pandemic\/marburg."},{"key":"ref_9","unstructured":"The United Nations Environment Programme (UNEP) (2020, July 07). Preventing the Next Pandemic\u2014Zoonotic Diseases and How to Break the Chain of Transmission. Available online: http:\/\/www.unenvironment.org\/resources\/report\/preventing-future-zoonotic-disease-outbreaks-protecting-environment-animals-and."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12985-019-1272-z","article-title":"Marburg Virus Pathogenesis\u2014Differences and Similarities in Humans and Animal Models","volume":"16","author":"Shifflett","year":"2019","journal-title":"Virol. J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.2217\/fvl.11.79","article-title":"Clinical Aspects of Marburg Hemorrhagic Fever","volume":"6","author":"Mehedi","year":"2011","journal-title":"Future Virol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Martini, G.A., and Siegert, R. (1971). Clinical Course and Prognosis of Marburg Virus (\u201cGreen-Monkey\u201d) Disease. Marburg Virus Disease, Springer.","DOI":"10.1007\/978-3-662-01593-3"},{"key":"ref_13","unstructured":"Hunter, N., and Rathish, B. (2025). Marburg Virus Disease. StatPearls, StatPearls Publishing."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ijid.2020.07.042","article-title":"Marburg Virus Disease: A Summary for Clinicians","volume":"99","author":"Kortepeter","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/pgmj.49.574.542","article-title":"Marburg Virus Disease","volume":"49","author":"Martini","year":"1973","journal-title":"Postgrad. Med. J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1084\/jem.20170161","article-title":"Marburg Virus Survivor Immune Responses Are Th1 Skewed with Limited Neutralizing Antibody Responses","volume":"214","author":"Stonier","year":"2017","journal-title":"J. Exp. Med."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Gordon, T.B., Hayward, J.A., Marsh, G.A., Baker, M.L., and Tachedjian, G. (2019). Host and Viral Proteins Modulating Ebola and Marburg Virus Egress. Viruses, 11.","DOI":"10.3390\/v11010025"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2011.07.018","article-title":"Differential Requirements for Clathrin Endocytic Pathway Components in Cellular Entry by Ebola and Marburg Glycoprotein Pseudovirions","volume":"419","author":"Bhattacharyya","year":"2011","journal-title":"Virology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1080\/21505594.2022.2054760","article-title":"Pathogenicity and Virulence of Marburg Virus","volume":"13","author":"Abir","year":"2022","journal-title":"Virulence"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Schmidt, K.M., and M\u00fchlberger, E. (2016). Marburg Virus Reverse Genetics Systems. Viruses, 8.","DOI":"10.3390\/v8060178"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"S232","DOI":"10.1086\/520584","article-title":"Basolateral Budding of Marburg Virus: VP40 Retargets Viral Glycoprotein GP to the Basolateral Surface","volume":"196","author":"Kolesnikova","year":"2007","journal-title":"J. Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Debroy, B., Chowdhury, S., and Pal, K. (2023). Designing a Novel and Combinatorial Multi-Antigenic Epitope-Based Vaccine \u201cMarVax\u201d against Marburg Virus\u2014A Reverse Vaccinology and Immunoinformatics Approach. J. Genet. Eng. Biotechnol., 21.","DOI":"10.1186\/s43141-023-00575-w"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nri2098","article-title":"How Ebola and Marburg Viruses Battle the Immune System","volume":"7","author":"Mohamadzadeh","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3109\/08830185.2010.529976","article-title":"Pathogen Recognition by the Innate Immune System","volume":"30","author":"Kumar","year":"2011","journal-title":"Int. Rev. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3390\/pathogens2020232","article-title":"Host-Viral Interactions: Role of Pattern Recognition Receptors (PRRs) in Human Pneumovirus Infections","volume":"2","author":"Kolli","year":"2013","journal-title":"Pathogens"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"9865","DOI":"10.1128\/JVI.01142-15","article-title":"Transcriptional Profiling of the Immune Response to Marburg Virus Infection","volume":"89","author":"Connor","year":"2015","journal-title":"J. Virol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"12090","DOI":"10.1128\/JVI.78.21.12090-12095.2004","article-title":"DC-SIGN and DC-SIGNR Interact with the Glycoprotein of Marburg Virus and the S Protein of Severe Acute Respiratory Syndrome Coronavirus","volume":"78","author":"Marzi","year":"2004","journal-title":"J. Virol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e00728-19","DOI":"10.1128\/mSphere.00728-19","article-title":"Rousette Bat Dendritic Cells Overcome Marburg Virus-Mediated Antiviral Responses by Upregulation of Interferon-Related Genes While Downregulating Proinflammatory Disease Mediators","volume":"4","author":"Prescott","year":"2019","journal-title":"mSphere"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s44298-024-00027-3","article-title":"Human Macrophages Infected with Egyptian Rousette Bat-Isolated Marburg Virus Display Inter-Individual Susceptibility and Antiviral Responsiveness","volume":"2","author":"Yordanova","year":"2024","journal-title":"npj Viruses"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.3390\/v3081501","article-title":"Intracellular Events and Cell Fate in Filovirus Infection","volume":"3","author":"Olejnik","year":"2011","journal-title":"Viruses"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1128\/JVI.78.6.2943-2947.2004","article-title":"Human Macrophage C-Type Lectin Specific for Galactose and N-Acetylgalactosamine Promotes Filovirus Entry","volume":"78","author":"Takada","year":"2004","journal-title":"J. Virol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1006\/viro.2002.1730","article-title":"DC-SIGN and DC-SIGNR Bind Ebola Glycoproteins and Enhance Infection of Macrophages and Endothelial Cells","volume":"305","author":"Simmons","year":"2003","journal-title":"Virology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1099\/0022-1317-76-2-393","article-title":"The Asialoglycoprotein Receptor Is a Potential Liver-Specific Receptor for Marburg Virus","volume":"76","author":"Becker","year":"1995","journal-title":"J. Gen. Virol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"5140","DOI":"10.1128\/JVI.02021-09","article-title":"Different Potential of C-Type Lectin-Mediated Entry between Marburg Virus Strains","volume":"84","author":"Matsuno","year":"2010","journal-title":"J. Virol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"7235","DOI":"10.1128\/JVI.00543-06","article-title":"Activation of Triggering Receptor Expressed on Myeloid Cells-1 on Human Neutrophils by Marburg and Ebola Viruses","volume":"80","author":"Mohamadzadeh","year":"2006","journal-title":"J. Virol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Roe, K., Gibot, S., and Verma, S. (2014). Triggering Receptor Expressed on Myeloid Cells-1 (TREM-1): A New Player in Antiviral Immunity?. Front. Microbiol., 5.","DOI":"10.3389\/fmicb.2014.00627"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0092-8674(01)00418-4","article-title":"Folate Receptor-\u03b1 Is a Cofactor for Cellular Entry by Marburg and Ebola Viruses","volume":"106","author":"Chan","year":"2001","journal-title":"Cell"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"M\u00fchlberger, E., Hensley, L.L., and Towner, J.S. (2017). Filovirus Strategies to Escape Antiviral Responses. Marburg- and Ebolaviruses: From Ecosystems to Molecules, Springer International Publishing.","DOI":"10.1007\/978-3-319-68948-7"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.virol.2015.03.030","article-title":"Innate Immune Evasion by Filoviruses","volume":"479\u2013480","author":"Basler","year":"2015","journal-title":"Virology"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Soltan, M.A., Abdulsahib, W.K., Amer, M., Refaat, A.M., Bagalagel, A.A., Diri, R.M., Albogami, S., Fayad, E., Eid, R.A., and Sharaf, S.M.A. (2022). Mining of Marburg Virus Proteome for Designing an Epitope-Based Vaccine. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.907481"},{"key":"ref_41","first-page":"241","article-title":"A Comparison of the Pathogenesis of Marburg Virus Disease in Humans and Nonhuman Primates and Evaluation of the Suitability of These Animal Models for Predicting Clinical Efficacy under the \u201cAnimal Rule\u201d","volume":"65","author":"Glaze","year":"2015","journal-title":"Comp. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/01913129809032253","article-title":"Marburg Hemorrhagic Fever: Report of a Case Studied by Immunohistochemistry and Electron Microscopy","volume":"22","author":"Geisbert","year":"1998","journal-title":"Ultrastruct. Pathol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0046-8177(72)80079-0","article-title":"The Morphology and Pathogenesis of \u201cMarburg Virus\u201d Hepatitis","volume":"3","author":"Bechtelsheimer","year":"1972","journal-title":"Hum. Pathol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1046\/j.1365-3156.2002.00945.x","article-title":"Short Communication: A Cluster of Marburg Virus Disease Involving an Infant","volume":"7","author":"Borchert","year":"2002","journal-title":"Trop. Med. Int. Health"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"S810","DOI":"10.1093\/infdis\/jir299","article-title":"Basic Clinical and Laboratory Features of Filoviral Hemorrhagic Fever","volume":"204","author":"Kortepeter","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Spengler, U., Fischer, H.-P., and Caselmann, W.H. (2011). Chapter 34\u2014Liver Disease Associated with Viral Infections. Zakim Boyer\u2019s Hepatol., 629\u2013643.","DOI":"10.1016\/B978-1-4377-0881-3.00034-6"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Zumbrun, E.E., Garvey, C.B., Wells, J.B., Lynn, G.C., Van Tongeren, S., Steffens, J.T., Wetzel, K.S., Gomba, L.M., O\u2019Brien, K.A., and Rossi, F.D. (2023). Characterization of the Cynomolgus Macaque Model of Marburg Virus Disease and Assessment of Timing for Therapeutic Treatment Testing. Viruses, 15.","DOI":"10.3390\/v15122335"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1473-3099(04)01103-X","article-title":"Pathogenesis of Filoviral Haemorrhagic Fevers","volume":"4","author":"Mahanty","year":"2004","journal-title":"Lancet Infect. Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ijid.2005.08.001","article-title":"Adrenal Infections","volume":"10","author":"Paolo","year":"2006","journal-title":"Int. J. Infect. Dis."},{"key":"ref_50","unstructured":"(2024, November 16). BMJ Best Practice Marburg Virus Infection\u2014Symptoms, Diagnosis and Treatment|BMJ Best Practice. Available online: https:\/\/bestpractice.bmj.com\/topics\/en-gb\/1615."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/labinvest.3780021","article-title":"Apoptosis Induced in Vitro and in Vivo during Infection by Ebola and Marburg Viruses","volume":"80","author":"Geisbert","year":"2000","journal-title":"Lab. Invest."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/path.4456","article-title":"Tissue and Cellular Tropism, Pathology and Pathogenesis of Ebola and Marburg Viruses","volume":"235","author":"Martines","year":"2015","journal-title":"J. Pathol."},{"key":"ref_53","first-page":"97","article-title":"Pathologic Features of Filovirus Infections in Humans","volume":"235","author":"ZAKI","year":"1999","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jcv.2015.01.014","article-title":"Ebola and Marburg Haemorrhagic Fever","volume":"64","author":"Rougeron","year":"2015","journal-title":"J. Clin. Virol."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Appel, M.J.G., Gillespie, J.H., and Siegert, R. (1972). Marburg Virus. Canine Distemper Virus: Marburg Virus, Springer.","DOI":"10.1007\/978-3-7091-8302-1"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/j.1365-4632.2011.05379.x","article-title":"Cutaneous Manifestations of Filovirus Infections","volume":"51","author":"Nkoghe","year":"2012","journal-title":"Int. J. Dermatol."},{"key":"ref_57","first-page":"e42014","article-title":"Advancements in Marburg (MARV) Virus Vaccine Research With Its Recent Reemergence in Equatorial Guinea and Tanzania: A Scoping Review","volume":"15","author":"Manohar","year":"2023","journal-title":"Cureus"},{"key":"ref_58","first-page":"332","article-title":"Past and Current Advances in Marburg Virus Disease: A Review","volume":"28","author":"Asad","year":"2020","journal-title":"Infez. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1093\/cid\/civ188","article-title":"Stopping Possible Sexual Transmission of Filoviruses","volume":"60","author":"Slanger","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.chom.2018.08.003","article-title":"Persistent Marburg Virus Infection in the Testes of Nonhuman Primate Survivors","volume":"24","author":"Coffin","year":"2018","journal-title":"Cell Host Microbe"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Zapata, J.C., Cox, D., and Salvato, M.S. (2014). The Role of Platelets in the Pathogenesis of Viral Hemorrhagic Fevers. PLOS Neglected Trop. Dis., 8.","DOI":"10.1371\/journal.pntd.0002858"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1172\/JCI116329","article-title":"Replication of Marburg Virus in Human Endothelial Cells. A Possible Mechanism for the Development of Viral Hemorrhagic Disease","volume":"91","author":"Schnittler","year":"1993","journal-title":"J. Clin. Investig."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Zarate-Sanchez, E., George, S.C., Moya, M.L., and Robertson, C. (2024). Vascular Dysfunction in Hemorrhagic Viral Fevers: Opportunities for Organotypic Modeling. Biofabrication, 16.","DOI":"10.1088\/1758-5090\/ad4c0b"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Manfrini, N., Notarbartolo, S., Grifantini, R., and Pesce, E. (2024). SARS-CoV-2: A Glance at the Innate Immune Response Elicited by Infection and Vaccination. Antibodies, 13.","DOI":"10.3390\/antib13010013"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1089\/jir.2009.0076","article-title":"Evasion of Interferon Responses by Ebola and Marburg Viruses","volume":"29","author":"Basler","year":"2009","journal-title":"J. Interferon Cytokine Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.3390\/v3091634","article-title":"Filoviral Immune Evasion Mechanisms","volume":"3","author":"Ramanan","year":"2011","journal-title":"Viruses"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"20661","DOI":"10.1073\/pnas.1213559109","article-title":"Structural Basis for Marburg Virus VP35\u2013Mediated Immune Evasion Mechanisms","volume":"109","author":"Ramanan","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1186\/ar567","article-title":"The Instructive Role of Dendritic Cells on T-Cell Responses","volume":"4","author":"Sallusto","year":"2002","journal-title":"Arthritis Res. Ther."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Liu, K. (2015). Dendritic Cells. Encycl. Cell Biol., 741\u2013749.","DOI":"10.1016\/B978-0-12-394447-4.30111-0"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1086\/379199","article-title":"Ebola and Marburg Viruses Replicate in Monocyte-Derived Dendritic Cells without Inducing the Production of Cytokines and Full Maturation","volume":"188","author":"Bosio","year":"2003","journal-title":"J. Infect. Dis."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Neurath, A. (2008). Immune Response to Viruses: Antibody-Mediated Immunity. Encycl. Virol., 56\u201370.","DOI":"10.1016\/B978-012374410-4.00591-4"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Kumar, A., Tripathi, P., Kumar, P., Shekhar, R., and Pathak, R. (2024). From Detection to Protection: Antibodies and Their Crucial Role in Diagnosing and Combatting SARS-CoV-2. Vaccines, 12.","DOI":"10.3390\/vaccines12050459"},{"key":"ref_73","first-page":"631","article-title":"Immunoglobulin M and G Responses Measured by Immunofluorescence in Patients with Lassa or Marburg Virus Infections","volume":"57","author":"Wulff","year":"1979","journal-title":"Bull. World Health Organ."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"e001112","DOI":"10.1136\/bmjgh-2018-001112","article-title":"Diagnostics for Filovirus Detection: Impact of Recent Outbreaks on the Diagnostic Landscape","volume":"4","author":"Emperador","year":"2019","journal-title":"BMJ Glob. Health"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41577-021-00558-3","article-title":"Natural Killer Cells in Antiviral Immunity","volume":"22","author":"Strunz","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1089\/vim.2008.0023","article-title":"Cellular Immune Response to Marburg Virus Infection in Cynomolgus Macaques","volume":"21","author":"Fritz","year":"2008","journal-title":"Viral Immunol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"S1021","DOI":"10.1093\/infdis\/jir339","article-title":"Pathogenesis of Marburg Hemorrhagic Fever in Cynomolgus Macaques","volume":"204","author":"Hensley","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"11025","DOI":"10.1128\/JVI.75.22.11025-11033.2001","article-title":"Infection and Activation of Monocytes by Marburg and Ebola Viruses","volume":"75","author":"West","year":"2001","journal-title":"J. Virol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1177\/0300985810378597","article-title":"Aerosol Exposure to the Angola Strain of Marburg Virus Causes Lethal Viral Hemorrhagic Fever in Cynomolgus Macaques","volume":"47","author":"Alves","year":"2010","journal-title":"Vet. Pathol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"S372","DOI":"10.1086\/520608","article-title":"Marburg Virus Angola Infection of Rhesus Macaques: Pathogenesis and Treatment with Recombinant Nematode Anticoagulant Protein C2","volume":"196","author":"Geisbert","year":"2007","journal-title":"J. Infect. Dis."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2006.08.018","article-title":"Release of Cellular Proteases into the Acidic Extracellular Milieu Exacerbates Ebola Virus-Induced Cell Damage","volume":"358","author":"Barrientos","year":"2007","journal-title":"Virology"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"6442","DOI":"10.1128\/JVI.72.8.6442-6447.1998","article-title":"Biochemical Analysis of the Secreted and Virion Glycoproteins of Ebola Virus","volume":"72","author":"Sanchez","year":"1998","journal-title":"J. Virol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1038\/sj.emboj.7600219","article-title":"Ectodomain Shedding of the Glycoprotein GP of Ebola Virus","volume":"23","author":"Dolnik","year":"2004","journal-title":"EMBO J."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1084\/jem.194.6.769","article-title":"Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo","volume":"194","author":"Hawiger","year":"2001","journal-title":"J. Exp. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.4049\/jimmunol.170.6.2797","article-title":"Cutting Edge: Impairment of Dendritic Cells and Adaptive Immunity by Ebola and Lassa Viruses","volume":"170","author":"Mahanty","year":"2003","journal-title":"J. Immunol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jaci.2009.12.980","article-title":"Overview of the Immune Response","volume":"125","author":"Chaplin","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"S234","DOI":"10.1093\/infdis\/jiv095","article-title":"Immune Response to Marburg Virus Angola Infection in Nonhuman Primates","volume":"212","author":"Fernando","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1038\/s41467-024-46226-7","article-title":"Coordinated Inflammatory Responses Dictate Marburg Virus Control by Reservoir Bats","volume":"15","author":"Guito","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"6404","DOI":"10.1128\/JVI.00126-09","article-title":"Development and Characterization of a Mouse Model for Marburg Hemorrhagic Fever","volume":"83","author":"Warfield","year":"2009","journal-title":"J. Virol."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Ciesielska-Figlon, K., and Lisowska, K.A. (2024). The Role of the CD28 Family Receptors in T-Cell Immunomodulation. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25021274"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.immuni.2016.05.002","article-title":"Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family","volume":"44","author":"Schildberg","year":"2016","journal-title":"Immunity"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"PD-1 and Its Ligands in Tolerance and Immunity","volume":"26","author":"Keir","year":"2008","journal-title":"Annu. Rev. Immunol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"51936","DOI":"10.18632\/oncotarget.17232","article-title":"PD1 Signal Transduction Pathways in T Cells","volume":"8","author":"Arasanz","year":"2017","journal-title":"Oncotarget"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00262-006-0272-1","article-title":"Contribution of the PD-L1\/PD-1 Pathway to T-Cell Exhaustion: An Update on Implications for Chronic Infections and Tumor Evasion","volume":"56","author":"Blank","year":"2007","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"5489","DOI":"10.3390\/v7102892","article-title":"The Role of Cytokines and Chemokines in Filovirus Infection","volume":"7","author":"Bixler","year":"2015","journal-title":"Viruses"}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/14\/4\/323\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:03:33Z","timestamp":1760029413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/14\/4\/323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,27]]},"references-count":95,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["pathogens14040323"],"URL":"https:\/\/doi.org\/10.3390\/pathogens14040323","relation":{},"ISSN":["2076-0817"],"issn-type":[{"value":"2076-0817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,27]]}}}